Er:YAG激光桩道预处理的研究进展

本文回顾了Er:YAG激光活化根管冲洗技术的最新研究进展,包括光子诱导光声流(photon initiated photoacoustic streaming,PIPS)技术和冲击波增强发射光声流(shock wave enhanced emission photoacoustic streaming,SWEEPS)技术,探讨Er:YAG激光预处理桩道的原理、优点以及对纤维桩粘接强度的影响,以期为临床选择适宜的桩道处理方法提供新思路。     

强脉冲光治疗浅表(皮肤)血管瘤临床观察

目的：观察强脉冲光（IPL）治疗浅表（皮肤）血管瘤的疗效。方法：选择60例浅表（皮肤）血管瘤患者,随机分为治疗组和对照组,治疗组用535nm、580nm强脉冲光治疗皮损,每三周治疗一次,三次为一个疗程;对照组采用波长为532nm的Q开关Nd：YAG激光治疗,每两周治疗一次,三次为一个疗程。观察两组皮损的治愈率、并发症等情况,并行统计学处理。结果：治疗组皮损三次治愈率明显高于对照组（P〈0.01）,患处瘢痕形成及炎症性色素沉着发生率均低于对照组。结论：强脉冲光（IPLTM）治疗浅表（皮肤）血管瘤效果满意。     

激光治疗膜性白内障：术前干涉视力测定的意义

应用激光干涉视力仪检测了23例(23只眼)膜性白内障Nd:YAG激光切开术前及术后的干涉视力,结果显示:术前与术后干涉视力之间的差异无显著性(P>0.05)。术前干涉视力与术后矫正视力呈正相关(P<0.05),提示半透明膜性白内障对激光干涉视力无显著影响.激光干涉视力是反映术后视力康复的可靠方法.但在具体分析时,应注意假阴性和假阳性的可能.65.2%的眼术后矫正视力高于术后干涉视力,反映了高度屈光不正的无晶体眼对激光干涉条纹在视网膜上的形成有一定的影响.     

钕钇铝石榴石激光治疗后囊混浊（353例）

采用钕钆铝石榴石激光切除白内障囊外摘除术后１０１例后房人工晶体植入后２５２例的后囊混浊共３５３例，激光治疗疗后视力均明显提高，矫正视力＞１．０者占８２．４％，无１例＜０．５。无明显并发症。     

Nd：YAG激光对牙本质钙／磷比值的影响

为探讨Ｎｄ：ＹＡＧ激光对牙本质矿物含量的影响，应用扫描电镜和能谱仪定点测量５０个上前牙标本的根管壁（激光照射工和正常对比区）的钙、磷含量，结果表明，照射区牙本质钙／磷（Ｃａ／Ｐ）比值高于对比区，当激光能量达１５Ｗ以上时变化更为显著，提示Ｎｄ：ＹＡＧ激光能提高牙本质的钙化程度。     

Q开关Nd:YAG激光不同波长治疗面部毛细血管扩张疗效比较

目的：观察Q开关Nd：YAG激光不同波长治疗面部毛细血管扩张的疗效及副反应。方法：128例病人按治疗波长随机分为532nm组75例，585nm组53例，治疗光斑2．0mm，能量密度2．2-6．8J／cm。，脉宽10ns；术后3个月根据术前照片判定疗效，标准分为Ⅳ级。结果：治疗次数1-4次，间隔时间3-5个月，两组共治愈71例(55，47％)，疗效与治疗次数成正相关。其中532nm组治愈36例(48．00％)，平均治愈次数2．64次；585nm组治愈35例(66．04％，)，平均治愈次数2．40次，两组痊愈率及副反应差异无显性。结论：Q开关Nd:YAG激光倍频532／nm和585nm两种波长对密度较低、直径较细的面部毛细血管扩张均有可靠疗效，术后除色素沉着发生较高外，其他不良反应较少。     

Nd:YAG激光加BCG膀胱灌注治疗浅表性膀胱癌

本文将45例经Nd:YAG激光治疗的膀胱癌患者随机分组,对33例做了卡介苗(BCG)膀胱灌注,12例做了噻替派(thiotepa)膀胱灌注,并分别随访了3～18个月,平均9.8个月,BCC组膀胱癌再发率3％(1/33),噻替派组膀胱癌再发率为25％(3/12)(P<0.01)。     

应用激光技术治疗痔—附1376例报告

本文较详细地介绍了应用激光技术即用CO_2及Nd:YAG激光手术刀治疗各种类型痔的临床观察。我院自1988年应用CO_2及Nd,YAG(以下简称激光手术刀)的技术治疗各种痔1376例均取得满意的治疗效果,治愈率达100％,并对有关问题进行探讨。     

Surgical treatment of metastatic lung tumors — Recent changes in techniques and indications

Between 1969 and 1995, 180 patients underwent complete resection of lung metastases during initial thoracotomy at our institute, involving the resection of 917 pulmonary nodules at 202 thoracotomy procedures. The overall postmetastasectomy 5- and 10-year survival rates were 46% and 30%, respectively. Of 111 patients who underwent segmentectomy and/or local excision, 57 had multiple metastases, 39 of whom were treated by Nd:YAG laser after 1986, and 18 by conventional procedures before 1985. The average number of tumors resected per patient treated with the Nd:YAG laser was significantly greater than that of those treated with conventional procedures. However, the survival curve of the laser-treated group was better than that of the laser-nontreated group. Moreover, slightly better survival was achieved in patients operated on after 1992 compared with those operated on before 1991. We conclude that the laser technique may be warranted to afford complete resection of metastases and adequate pulmonary reservation in combination with a selected approach for thoracotomy under the exact detection of tumor localization using the most recent high-quality computed tomography (CT) scan. Furthermore, a one-stage operation to control synchronous intra- and extrapulmonary malignamcies may become a possible option in combination with selective adjunctive therapy.